Use of nepafenac (Nevanac(®)) in combination with intravitreal anti-VEGF agents in the treatment of recalcitrant exudative macular degeneration requiring monthly injections

PURPOSE: The purpose of this study is to determine the efficacy of combining topical nepafenac with monthly intravitreal injections of ranibizumab or bevacizumab in the treatment of recalcitrant exudative macular degeneration. METHODS: This was a retrospective, consecutive case series of patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Eric, Benz, Matthew S, Fish, Richard H, Brown, David M, Wong, Tien P, Kim, Rosa Y, Major, James C
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993124/
https://www.ncbi.nlm.nih.gov/pubmed/21151329
http://dx.doi.org/10.2147/OPTH.S14092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993124/
https://www.ncbi.nlm.nih.gov/pubmed/21151329
http://dx.doi.org/10.2147/OPTH.S14092

Ejemplares similares